Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

ICAAC, September 17-20 in Toronto

August 18, 2000

The 40th Interscience Conference on Antimicrobial Agents and Chemotherapy will take place September 17-20, 2000, at the Metro Toronto Convention Centre, Toronto, Ontario, Canada. This annual conference, organized by the American Society for Microbiology in Washington D.C., usually attracts about 10,000 people; it focuses on new developments in antibiotics, and includes substantial HIV presentations.

Comment: We usually find the HIV/AIDS presentations less important in even-numbered years, when ICAAC competes with the International AIDS Conference. But this year a number of researchers did not go to Durban, South Africa, for the international meeting, so this ICAAC may be more important than most which occur on International AIDS Conference years. And researchers who did present in Durban are more likely to speak in Toronto as well, as much of the audience there did not get to Durban.

The abstracts for the ICAAC conference (except for late breakers) will be online later this month, and can be found through the main ICAAC conference page, http://www.asmusa.org/mtgsrc/40icaac.htm.

Meanwhile, a preliminary list of oral presentations is already online; we selected the following, which may be of interest to our readers:

    Advertisement

  • Update in Infectious Diseases. Conveners Ferric C. Fang, Robert T. Schooley, and David A. Relman. An overview of last year's most noteworthy papers on infectious diseases.

  • Keynote Session: HIV/AIDS: From Discovery, to Prevention and Therapy. Conveners David A. Cooper, Michael S. Saag, and H. Clifford Lane: AIDS as a Zoonosis: Scientific and Public Health Implications, Beatrice H. Hahn: Progress in HIV Vaccine Development, Gary J Nabel: Antiretroviral Therapy -- A Limited Success Story.

  • In Emerging Infections section: Emerging MRSA in the Community, Julie L. Gerberding, CDC, Atlanta; The Growing Challenge of Fresh Produce-associated Foodbourne Infections, Cindy R. Friedman; Amebiasis: It Was Always There and We Didn't Know It, William A. Petri.

  • In DNA Sequencing as a Diagnostic Tool: Getting to First Base: Using DNA Sequencing to Monitor Resistance in HIV, Robert W. Shafer.

  • In Innate Immunity: Antimicrobial Peptides, Tomas Ganz.

  • Lipodystrophy and Metabolic Complications of HIV, Conveners David A. Cooper, Michael S. Saag, and H. Clifford Lane: Mitochondrial Toxicity: Mechanism and Spectrum, William Lewis; Mechanism and Treatment for Insulin Resistance in HIV Lipodystrophy, Steven K. Grinspoon; Cardiovascular Epidemiology in the Context of HIV Disease, Matthias Egger; The Strategy of Antiretroviral Switch Studies -- A Review, William G. Powderly.

  • T-cell Responses to Viruses, Conveners Paul D. Griffiths and Louis J. Picker: Laboratory Techniques, L.K. Borysiewicz; HIV and CMV, Louis J. Picker; Epstein-Barr Virus and Adoptive T-Cell Therapy, Cliona Rooney; HCV, Rodney E. Phillips.

  • Tuberculosis: Problems and Promises, Conveners Renee Ridzon and Jerrold J. Ellner: New Insights into the Transmission of TB, Renee Ridzon; How Molecular Approaches Contribute to Our Understanding of TB, Barry N. Kreiswirth; Understanding the Pathogenesis of Tuberculosis and the Implications for Immunotherapy, Gilla Kaplan; Microbiological Monitoring of Tuberculosis for Therapeutic Endpoints, Robert S. Wallis; Is Tuberculosis a Vaccine-preventable Illness? What's on the Horizon? William Jacobs.

  • Viral Co-infections with HIV, Conveners TBA: HHV-8 and HIV, Lawrence Corey; Hepatitis C, David Thomas; CMV, Michael Polis.

  • Current Issues in the Management of HIV-infected Patients, Conveners Paul A. Volberding and Constance A. Benson: The Clinical Use of Resistance Testing, Douglas D. Richman; Management of Metabolic Complications of Therapy, Judith S. Currier; The Dilemma of Treatment Interruption, Roy M. Gulick.

  • Also, several of the Meet-the-Experts Roundtables are relevant: Antiretroviral Therapy I, with Christine Katlama and Robert L. Murphy. Antiretroviral Therapy II, with William Cameron and Calvin Cohen. Antiretroviral Therapy III, with Roy M. Gulick and Michael S. Saag. Infection Control in Multidrug-resistant Pathogens [antibiotic resistance, not antiretroviral], with Robert A. Weinstein and John M. Conly. Stopping Opportunistic Infection Prophylaxis, with Henry Masur and Wafaa El-Sadr. What to Do When the Condom Breaks, with James Kahn and Julie L. Gerberding.


    Registration, Housing, Other Information

    Registration and other information is available through the ICAAC Web site, http://www.asmusa.org/mtgsrc/40icaac.htm. This conference is relatively inexpensive; general onsite registration is $350.



    ISSN # 1052-4207

    Copyright 2000 by John S. James. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used.


    Back to the AIDS Treatment News August 18, 2000 contents page.




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDS Treatment News. It is a part of the publication AIDS Treatment News.
 

Tools
 

Advertisement